Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - TME Pharma NV - TME PHARMA CEO MESSAGE
TME PHARMA CEO MESSAGE
GlobeNewswire

Berlin, Germany, September 16, 2026, 8.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for brain cancer and eye diseases, today publishes a…

wsj.com - Nikkei Rises 1.0%, Led by Pharma, Machinery Stocks
Nikkei Rises 1.0%, Led by Pharma, Machinery Stocks
Wall Street Journal

0015 GMT — Japanese stocks are higher, supported by bargain-hunting, as recent rising momentum in crude oil eases. Pharmaceutical and machinery stocks are leading gains. Eisai is up 2.4% and is 3.2% higher. The dollar is at 155.87 yen, up…

ndtv.com - Abhishek Sureshkumar Awasthi - Exclusive: After Survey Flags 2,800% Pharma Profit, Tukaram Mundhe Calls For Transparency
Exclusive: After Survey Flags 2,800% Pharma Profit, Tukaram Mundhe Calls For Transparency
NDTV

'Basically there has to be a fair trade, fair margin of profit.,' Tukaram Mundhe said. Summary is AI-generated, newsroom-reviewed Maharashtra FDA found up to 2800% profit margin on IV sets sold to hospitals and consumers Maharashtra FDA wrote to…

seekingalpha.com - Petri Dish Reports - SOPHiA Genetics: Scaling Phase Begins As U.S. And Pharma Monetisation Inflect (SOPH)
SOPHiA Genetics: Scaling Phase Begins As U.S. And Pharma Monetisation Inflect (SOPH)
Seeking Alpha

SOPHiA GENETICS SA is entering a scale-and-monetize phase, with its genomic intelligence platform validated and execution now the main focus. U.S. adoption, liquid biopsy expansion, and early biopharma/CDx commercialization—highlighted by…

seekingalpha.com - SA Transcripts - Zealand Pharma A/S (ZLDPY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Zealand Pharma A/S (ZLDPY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha

Zealand Pharma A/S (ZLDPY) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 11:30 AM EDT Adam Steensberg - President & CEO Cool. Well, thank you all for being here. I'm James Machin from the Morgan Stanley banking team and…

newswire.ca - Piramal Pharma Solutions Advances Sustainability Efforts with Solar Power Plant Addition at Morpeth, UK Site
Piramal Pharma Solutions Advances Sustainability Efforts with Solar Power Plant Addition at Morpeth, UK Site
CNW

Piramal Pharma Solutions is installing a ground-mounted solar power plant (4.3 MWp) at its integrated drug substance and drug product site in Morpeth, UK. The new plant will provide renewable energy directly to the site through a behind-the-meter…

thehill.com - The HIll Staff - Watch live: Trump's pick for surgeon general faces Senate confirmation hearing
Watch live: Trump's pick for surgeon general faces Senate confirmation hearing
The Hill

Dr. Nicole Saphier, whom President Trump tapped to serve as U.S. surgeon general, will testify before the Senate Health, Education, Labor and Pensions Committee on Wednesday morning. Saphier, a media personality, was the third person Trump picked…

marketbeat.com - NewAmsterdam Pharma (NASDAQ:NAMS) Reaches New 12-Month Low - Here's Why
NewAmsterdam Pharma (NASDAQ:NAMS) Reaches New 12-Month Low - Here's Why
MarketBeat

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) reached a new 52-week low during trading on Wednesday. The stock traded as low as $21.08 and last traded at $21.16, with a volume of 1732731 shares trading hands. The stock had…

newstatesman.com - Freddie Hayward - Donald Trump's last hurrah
Donald Trump's last hurrah
The Newstatesman

Donald Trump wanted us to share in a collective delusion. On stage at the Republican convention in Dallas, Texas, looking out at a mass of empty seats, he was telling us that they were full. He could see the empty seats. We could see the empty…

sputnikglobe.com - Moscow and Delhi Expand Investment and Industrial Cooperation
Moscow and Delhi Expand Investment and Industrial Cooperation
Sputnik International

A Moscow government delegation held around 200 meetings with Indian officials, business associations and companies during a visit to India, according to Anatoly Garbuzov, Moscow Government Minister and head of the city's Department of Investment…

seekingalpha.com - Edmund Ingham - Novo Nordisk: Why This Corporate Rebrand Is More Than Simply PR Posturing (NYSE:NVO)
Novo Nordisk: Why This Corporate Rebrand Is More Than Simply PR Posturing (NYSE:NVO)
Seeking Alpha

Novo Nordisk A/S has rebranded as 'Novo' with a new strategy, aiming for greater consumer focus and operational agility amid intensifying GLP-1 competition. NVO's GLP-1 franchise faces mounting pressure from Eli Lilly's superior market share and…

fastcompany.com - Hunter Schwarz - Does Novo Nordisk's slimmed down rebrand signal a new era of DTC revivalism?
Does Novo Nordisk's slimmed down rebrand signal a new era of DTC revivalism?
Fast Company

Novo Nordisk, the Dandish drugmaker behind the weight-loss drugs Ozempic and Wegovy, announced it's rebranding to “Novo” beginning this week. It's part of a larger trend in healthcare branding. The rise of telehealth…

forbes.com - Bill Holodnak - Your Biotech Career Is Only As Secure As Your Ability To Keep Learning
Your Biotech Career Is Only As Secure As Your Ability To Keep Learning
Forbes

Bill Holodnak, CEO and Founder of Occam Global, an executive search and advisory firm focused on leadership across the innovation economy. ​For years, the career advice in life sciences was straightforward: If you wanted stability, join a…

fool.com - Adria Cimino - My Top 5 Favorite Stocks for an Uncertain Market
My Top 5 Favorite Stocks for an Uncertain Market
The Motley Fool

The S&P 500 has climbed this year, adding to three consecutive years of gains. But with levels near record highs, valuations relatively high, and concerns about artificial intelligence (AI) spending and rising inflation brewing, some investors have…

newswire.ca - Cumulus Neuroscience Presents Data at the ISCTM 2026 Autumn Conference
Cumulus Neuroscience Presents Data at the ISCTM 2026 Autumn Conference
CNW

Interim data show high adherence and usability for remote, multimodal brain monitoring in borderline personality disorder and therapy-resistant depression, and a two-minute digital cognitive task performing comparably to clinical benchmarks for…

Receive a Daily briefing on Pharma Industry News

Get Started